Navigation Links
AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting
Date:7/23/2009

MARKHAM, ON, July 23 /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX) announced positive preclinical results which demonstrated that an inhaled tobramycin nanoparticle (Zysolin(TM)) formulation was a more effective treatment in animal models of acute Pseudomonas aeruginosa pneumonia when compared to inhaled and injected conventional tobramycin solutions. The data was presented recently in an oral podium session at the 36th Annual Meeting and Exposition of the Controlled Release Society in Copenhagen, Denmark.

"These are very encouraging results, as they suggest that Zysolin(TM) employed in this route of administration may be more effective, providing significant advantages over conventional drug formulations," stated Joseph Schwarz, Ph.D., Chief Scientist of AlphaRx. "We believe that building on this data, additional research will lead us toward the development of a drug that targets and eradicates intracellular pathogens, which to date, have proven to be very difficult to treat clinically."

The study results demonstrate that Zysolin(TM) is significantly efficacious in acute pneumonia animal models induced by gram negative pathogens including P. aeruginosa. In these lethality-based studies, Zysolin(TM) consistently increased survival rate to 50% over a Tobramycin treatment group, wherein all untreated animals died within 24 hours after infection. P. aeruginosa is one of the most common and lethal pathogens responsible for ventilator-associated pneumonia in intubated patients, being directly responsible for death rates approaching 40%. This data suggests that the nanoparticulate formulation of Zysolin(TM) may utilize a unique mechanism of action differentiating it from conventional formulations, enhancing antimicrobial activity against gram negative pathogens. Zysolin(TM) has the potential to be a first-in-class anti-infective nanomedicine.

The Controlled Release Society (CRS) is an international organization consisting of 3,000 mem
'/>"/>

SOURCE AlphaRx Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AlphaRx Unveils its China Strategy
2. AlphaRx Reports Positive Preclinical Data on GAI-122 Against Liver Disease
3. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
4. AlphaRx Shareholder Update
5. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
6. AlphaRx Signs Cooperative Research and Development Agreement with US Army
7. AlphaRx Provides Corporate and Development Update
8. AlphaRxs Indaflex(TM) Continues its Clinical Development
9. AlphaRx CEO Accumulates More Company Shares
10. AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares
11. AlphaRx Announces Debt Conversion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... ... announce that their latest designer handbag line will be named for Madeline Stuart, ... sensation as the first globally recognized model with Down syndrome, gracing the front ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... has announced plans to release a newly redesigned website at Healthpointe.net. The new ... enhanced user experience. , The redesign serves to provide smoother interactions between ...
(Date:7/31/2015)... ... , ... ZH Healthcare announces a new cloud based service delivering Health IT ... a Service (HITaaS) is a Healthcare dedicated cloud based service that sits over infrastructure ... manages all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, contracts, ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Medicine Practice, and Hospital Medicine Practice, is pleased to announce that it has ... mobile application format available on iPhones, iPads, and Android smartphones and tablets. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Radiology ... Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol ... and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding of ...
Breaking Medicine News(10 mins):Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:Healthpointe Announces Newly Redesigned Website 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3
... Provides Best-of-Suite Technology, Streamlines ... ... Oct. 23 ,Medsphere Systems Corporation and Keane, Inc. today announced ... integrated best-of-suite clinical and financial software. The alliance,leverages Medsphere,s OpenVista(R) ...
... Palmetto GBA, a leading,provider of technical and administrative ... selected as a subcontractor as part,of a contract awarded ... for information technology modernization. Palmetto GBA is part ... for the unrestricted portions of CMS, Enterprise System,Development (ESD) ...
... incentives to health workers in low-income countries may hold the ... young children, according to a study published on bmj.com ... expert panel as one of eight of the most outstanding ... policy and will be presented at the launch of the ...
... Brings Additional Key Gene Locus as a ... for Recently-Funded Company, NEW HAVEN, Conn., Oct. 23 ... diagnose dry and wet Age-related Macular,Degeneration (AMD) and other ... it has licensed from the University,of Pittsburgh the worldwide ...
... Oct. 23 GeneGo, Inc., a leading,provider of ... they have licensed their MetaCore Data Mining Suite ... novel GeneGo,disease enrichment and functional ontology. MetaCore has ... the unique ability to concurrently,visualize gene expression, proteomics, ...
... designed to connect healthcare communities throughout ... ... During the World of,Health IT Conference and Exhibition today in Vienna, ... broad expansion of the Microsoft Healthcare Users Group (MS-HUG) to,partners and ...
Cached Medicine News:Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 2Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 3Health News:Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems 4Health News:Palmetto GBA Selected as Subcontractor for CMS' Enterprise System Development Project 2Health News:Financial incentives may hold key to cutting child malaria deaths 2Health News:Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations 2Health News:Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations 3Health News:GeneGo Licenses MetaCore Data Analysis Suite to AVEO Pharmaceuticals 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4
(Date:7/31/2015)... HYDERABAD, India , July 31, 2015 /PRNewswire/ ... Billing and CRM solutions for video, data and cloud ... (PoC) with a leading pharma giant for Internet ... managing different IoT applications offered on subscription model. ... Pharma giant is striving for business ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... , , , , ... i c , Inc. (Nasdaq: ... medical imaging systems and surgical products dedicated to serving the healthcare needs ... study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic ...
... VIENNA, Va., Aug. 18 CEL-SCI Corporation (NYSE Amex: ... of its work towards creating a novel treatment and vaccination against ... in which the virus has acquired greater morbidity and mortality. ... are highly conserved and essential for the virus, survival. This ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4CEL-SCI Expands H1N1 Flu Virus Work 2CEL-SCI Expands H1N1 Flu Virus Work 3
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator....
Medicine Products: